Stay updated with breaking news from Dimpyp shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Covishield vaccination accepted in Switzerland, 7 EU countries Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers. The study, published in the journal Cancer Cell, indicated that among the 131 patients studied, 94 per cent developed antibodies to the coronavirus. Seven high-risk patients did not. Russia Coronavirus Vaccine YouTube Grab/Sputnik We could not find any antibodies against the virus in those patients, said researcher Dimpy P. Shah from the University Of Texas Health Science Center at San Antonio. ....
94% of cancer patients respond to COVID vaccine: Researchers sentinelassam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sentinelassam.com Daily Mail and Mail on Sunday newspapers.
94% of patients with cancer respond well to Covid vax: Study prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
94% of patients with cancer respond well to coronavirus vax: Study business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Around 94 per cent of patients with cancer respond well to COVID vaccines, finds new study edexlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edexlive.com Daily Mail and Mail on Sunday newspapers.